Pacific Biosciences of California, Inc. v. Oxford Nanopore Technologies, Inc.
1:17-cv-00275
Overview
Parties
Defendant
Oxford Nanopore Technologies, Ltd. NPE (Patent Assertion Entity)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Baker & Hostetler
Baker & Hostetler, 1201 North Market Street
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Oxford Nanopore Technologies, Inc. NPE (Patent Assertion Entity)
Represented By
6 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Baker & Hostetler
Baker & Hostetler, 1201 North Market Street
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Plaintiff
Pacific Biosciences of California, Inc. Operating Company
Represented By
8 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Oxford Nanopore Technologies, Inc. et al. v. Pacific Biosciences of California, Inc.
Oxford Nanopore Technologies, Inc. et al. v. Pacific Bioscienes of California, Inc.
Oxford Nanopore Technologies, Inc. et al. v. Pacific Biosciences of California, Inc.
Oxford Nanopore Technologies, Inc. et al. v. Pacific Biosciences of California, Inc.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9546400
Nanopore sequencing using n-mers
|
Filed: 2013-09-13
Issued: 2017-01-17
|
Active (3.8 yrs remaining)
Expires: 2030-08-31
|
|
|
US9678056
Control of enzyme translocation in nanopore sequencing
|
Filed: 2016-12-01
Issued: 2017-06-13
|
Active (10.0 yrs remaining)
Expires: 2036-12-01
|
|
|
US9738929
Nucleic acid sequence analysis
|
Filed: 2016-12-19
Issued: 2017-08-22
|
Active (10.1 yrs remaining)
Expires: 2036-12-19
|
|
|
US9772323
Nanopore sequencing using N-mers
|
Filed: 2017-02-22
Issued: 2017-09-26
|
Active (10.3 yrs remaining)
Expires: 2037-02-22
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
55
Dispositive
19
Granted
2
Denied
3
Pending / Review
50
Motions by Category
Key Dispositive Motions & Rulings